(Q45945783)

18 December 2017

title

Susceptibility of 228 non-fermenting gram-negative rods to tigecycline and six other antimicrobial drugs. (English)

1 reference

18 December 2017

main subject

Gram-negative bacteria

0 references

author name string

Gómez-Garcés JL

1

1 reference

18 December 2017

Aracil B

2

1 reference

18 December 2017

Gil Y

3

1 reference

18 December 2017

Burillo A

4

1 reference

18 December 2017

publication date

1 June 2009

1 reference

18 December 2017

published in

Journal of Chemotherapy

1 reference

18 December 2017

volume

21

1 reference

18 December 2017

issue

3

1 reference

18 December 2017

page(s)

267-271

1 reference

18 December 2017

Potentially multidrug-resistant non-fermentative Gram-negative pathogens causing nosocomial pneumonia

cites work

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2009.21.3.267

Global epidemiology of antimicrobial resistance among community-acquired and nosocomial pathogens: a five-year summary from the SENTRY Antimicrobial Surveillance Program (1997-2001).

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2009.21.3.267

Presence of tetracycline resistance determinants and susceptibility to tigecycline and minocycline

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2009.21.3.267

Tigecycline: what is it, and where should it be used?

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2009.21.3.267

Contemporary assessment of antimicrobial susceptibility testing methods for polymyxin B and colistin: review of available interpretative criteria and quality control guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2009.21.3.267

Susceptibilities of 123 strains of Xanthomonas maltophilia to eight beta-lactams (including beta-lactam-beta-lactamase inhibitor combinations) and ciprofloxacin tested by five methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2009.21.3.267

Clinical impact and pathogenicity of Acinetobacter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2009.21.3.267

Endemic carbapenem-resistant Acinetobacter species in Brooklyn, New York: citywide prevalence, interinstitutional spread, and relation to antibiotic usage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2009.21.3.267

Colistin treatment in patients with ICU-acquired infections caused by multiresistant Gram-negative bacteria: the renaissance of an old antibiotic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2009.21.3.267

In vitro activities of tigecycline (GAR-936) against recently isolated clinical bacteria in Spain

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2009.21.3.267

Antimicrobial activity of tigecycline tested against organisms causing community-acquired respiratory tract infection and nosocomial pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2009.21.3.267

Susceptibility to beta-lactam antibiotics of mutant strains of Xanthomonas maltophilia with high- and low-level constitutive expression of L1 and L2 beta-lactamases

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2009.21.3.267

A changing pattern of susceptibility of Xanthomonas maltophilia to antimicrobial agents: implications for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2009.21.3.267

Efflux-mediated resistance to tigecycline (GAR-936) in Pseudomonas aeruginosa PAO1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2009.21.3.267

10.1179/JOC.2009.21.3.267

21 January 2018

Identifiers

DOI

1 reference

18 December 2017

PubMed ID

19567346

1 reference

18 December 2017